Oculogica
company
About
Oculogica specializes in the fields of neuro-diagnostics, brain injury, TBI, concussion, and eye tracking.
- 1 - 10
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $8.17M
- Industries
- Health Care,Health Diagnostics,Medical,Neuroscience
- Founded date
- Jan 1, 2013
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Oculogica is a medical device manufacturing company that specializes in the fields of neuro-diagnostics, brain injury, TBI, concussion, and eye-tracking. The company's EyeBOX device is the only baseline-free test authorized by the FDA as an aid in the diagnosis of concussion, also known as mild traumatic brain injury (mTBI). It requires no baseline data nor individual calibration, and therefore results cannot be influenced by patient will.Oculogica was established in 2013 and is based in New York, NY, United States.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$10.17M
Oculogica has raised a total of
$10.17M
in funding over 2 rounds. Their latest funding was raised on
May 18, 2021 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| May 18, 2021 | Grant | $2M | 1 |
U.S. Army Medical Research & Development Command
|
— | Detail |
| Jul 17, 2019 | Series A | $8.17M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
1
2
Oculogica is funded by 2 investors.
U.S. Army Medical Research & Development Command
and Colle Capital Partners
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
U.S. Army Medical Research & Development Command
|
Yes | Grant |
Colle Capital Partners
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
